|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 17 studies with search of: | Open Studies | "Rosacea" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Open Label Pilot Study of Apremilast in Treatment of Rosacea
|
||||
| 2 | Recruiting |
Atralin Gel for the Treatment of Rosacea
|
||||
| 3 | Not yet recruiting |
Rifaximin Treatment of Papulopustular Rosacea
|
||||
| 4 | Recruiting |
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
|
||||
| 5 | Recruiting |
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
|
||||
| 6 | Recruiting |
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
|
||||
| 7 | Recruiting |
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
|
||||
| 8 | Recruiting |
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
|
||||
| 9 | Not yet recruiting |
A Study of DER 45-EV Gel to Treat Rosacea
|
||||
| 10 | Recruiting |
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
|
||||
| 11 | Recruiting |
A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155 AM1)
|
||||
| 12 | Recruiting |
Phase 3 Papulopustular Rosacea Study
|
||||
| 13 | Not yet recruiting |
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
|
||||
| 14 | Recruiting |
Phase 3 Papulopustular Rosacea Study
|
||||
| 15 | Recruiting |
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
|
||||
| 16 | Recruiting |
Potential Research Study Participant Registry
|
||||
| 17 | Recruiting |
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
|